These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10441404)

  • 1. Alternatives to Animals in the Development and Control of Biological Products for Human and Veterinary Use. Zoological Society, London, UK, 24-26 September 1998.
    Sesardic D; Hendriksen CF
    Biologicals; 1999 Mar; 27(1):55-7. PubMed ID: 10441404
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement, Reduction and Refinement of Animal Experiments in the Development and Control of Biological Products. Proceedings of a conference. Langen, Germany, November 2-4, 1994.
    Dev Biol Stand; 1996; 86():1-368. PubMed ID: 8785937
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternatives to Animals in the Development and Control of Biological Products for Human and Veterinary Use. London, United Kingdom, September 24-26, 1998. Proceedings.
    Dev Biol Stand; 1999; 101():1-335. PubMed ID: 10610328
    [No Abstract]   [Full Text] [Related]  

  • 4. Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.
    Dev Biol (Basel); 2012; 134():149-52. PubMed ID: 22888608
    [No Abstract]   [Full Text] [Related]  

  • 5. [Official testing of immunological veterinary medicinal products].
    Jungbäck C; Motitschke A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1193-7. PubMed ID: 25168840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological assays: their role in the development and quality control of recombinant biological medicinal products.
    Mire-Sluis AR; Gerrard T; Das RG; Padilla A; Thorpe R
    Biologicals; 1996 Dec; 24(4):351-62. PubMed ID: 9088552
    [No Abstract]   [Full Text] [Related]  

  • 7. Requirements for valid alternative assays for testing of biological therapeutic agents.
    Sesardic D
    Dev Biol Stand; 1996; 86():311-8. PubMed ID: 8785962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays.
    Lewis CE; Fry AM; Hermann JR; Siev D; Dusek DM; Gatewood DM
    Dev Biol (Basel); 2012; 134():29-33. PubMed ID: 22888592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The validation of potency tests: hurdles identified by EMA/CVMP/IWP.
    Woodland R
    Dev Biol (Basel); 2012; 134():69-73. PubMed ID: 22888597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress and future directions for reduction, refinement, and replacement of animal use in veterinary vaccine potency and safety testing: a report from the 2010 NICEATM-ICCVAM International Vaccine Workshop.
    Stokes WS; Kulpa-Eddy J; Brown K; Srinivas G; McFarland R
    Dev Biol (Basel); 2012; 134():9-21. PubMed ID: 22888590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of alternative methods by the EDQM and the Biological Standardization Program].
    Buchheit KH
    ALTEX; 2001; 18(1):19-22. PubMed ID: 11248845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards in vitro potency testing of inactivated erysipelas vaccines.
    Balks E; Wolf C; Loessner H; Werner E
    Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro vaccine potency testing: a proposal for reducing animal use for requalification testing.
    Brown K; Stokes W
    Dev Biol (Basel); 2012; 134():75-81. PubMed ID: 22888598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The five Rs: refinement, reduction, replacement. A regulatory revolution.
    Lucken RN
    Dev Biol Stand; 1996; 86():67-72. PubMed ID: 8785993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vaccines consistency approach project: an EPAA initiative.
    De Mattia F; Hendriksen C; Buchheit KH; Chapsal JM; Halder M; Lambrigts D; Redhead K; Rommel E; Scharton-Kersten T; Sesardic T; Viviani L; Ragan I
    Pharmeur Bio Sci Notes; 2015; 2015():30-56. PubMed ID: 26830158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using polyclonal and monoclonal antibodies in regulatory testing of biological products.
    Coe Clough NE; Hauer PJ
    ILAR J; 2005; 46(3):300-6. PubMed ID: 15953837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in animal use in the production and testing of biologicals.
    Festing MF
    Dev Biol Stand; 1999; 101():195-200. PubMed ID: 10566793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of veterinary biological products for fish in the United States.
    Birnbaum NG
    Dev Biol Stand; 1997; 90():335-40. PubMed ID: 9270861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives to the use of animals in R & D and quality control of veterinary vaccines: an industry view.
    Verschueren C; Zänker S
    Dev Biol Stand; 1996; 86():49-51. PubMed ID: 8785991
    [No Abstract]   [Full Text] [Related]  

  • 20. The target animal safety test--is it still relevant?
    Advisory Group on Alternatives to Animal Testing in Immunobiologicals
    Biologicals; 2002 Dec; 30(4):277-87. PubMed ID: 12474863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.